When：09-22 September 2026   |  Where：China Guangzhou

September 22-23

China Guangzhou

Track 6：

iPSC and Clinical Transformation

• Stem cells
• Regenerative Medicine
• MSCs vs iPSCs
• Organoids and exosomes
• Anti-aging
• Regulatory challenges

• Application for treatment of more            common diseases
• Tackling immunogenicity
• Rare diseases & orphan drugs
• Novel gene AAV delivery systems
• Oncolytic Virus

• Automation & closed systems
• Scaling up to commercial level
• Keeping costs low
• Decentralized and Point-of-care                           manufacturing
• Quality Control
• CMC, Analytics and Safety

• Immunotherapy for solid tumours
• In vivo cell therapy
• TILs
• Car-NK
• mRNA based TCR-T

• Safety and ethical considerations
• CRISPR/Cas9
• Clinical trials development

• Ensuring clinical success
• Clinical and nursing perspectives
• Transitioning from clinical to commercial
• Cold Chain

If you are interested in roadshow presentation, please contact:

Mr.Jeff Lim

Jeff.lim@xperiobio.com

Track 2：

in vivo Cell Therapy Breakthrough and outlook

DAY 2

Morning

DAY 1

Morning

DAY 1

Afternoon

DAY 2

Afternoon

Track 4：

Next Gen Cell Therapy-Outbreaking 

Progress in Solid Tumer 

Track 1：

International Insights and Cooperation

Track 9：

Gene Therapy and Delivery Technology- CNS and Ophthalmology  

Track 3：

Next Gen Cell Therapy: Autoimmune Disease and Universal Cellular Therapy

Track 7：

Exosomes Technology

Track 5：

Stem Cell and Regenerative medicine

Track 8：

Exosomes and Anti-aging

Close Door Meeting